- Home
- ABUS vs AC Comparison
ABUS vs AC Comparison
Compare ABUS & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- AC
- Stock Information
- Founded
- ABUS N/A
- AC 1976
- Country
- ABUS United States
- AC United States
- Employees
- ABUS N/A
- AC N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- AC Investment Bankers/Brokers/Service
- Sector
- ABUS Health Care
- AC Finance
- Exchange
- ABUS Nasdaq
- AC Nasdaq
- Market Cap
- ABUS 725.9M
- AC 765.5M
- IPO Year
- ABUS N/A
- AC N/A
- Fundamental
- Price
- ABUS $3.46
- AC $36.71
- Analyst Decision
- ABUS Strong Buy
- AC
- Analyst Count
- ABUS 4
- AC 0
- Target Price
- ABUS $5.50
- AC N/A
- AVG Volume (30 Days)
- ABUS 837.4K
- AC 5.4K
- Earning Date
- ABUS 11-06-2024
- AC 11-08-2024
- Dividend Yield
- ABUS N/A
- AC 0.27%
- EPS Growth
- ABUS N/A
- AC 65.12
- EPS
- ABUS N/A
- AC 2.62
- Revenue
- ABUS $6,742,000.00
- AC $13,657,000.00
- Revenue This Year
- ABUS N/A
- AC N/A
- Revenue Next Year
- ABUS N/A
- AC N/A
- P/E Ratio
- ABUS N/A
- AC $13.84
- Revenue Growth
- ABUS N/A
- AC N/A
- 52 Week Low
- ABUS $1.79
- AC $28.58
- 52 Week High
- ABUS $4.72
- AC $43.85
- Technical
- Relative Strength Index (RSI)
- ABUS 30.63
- AC 44.89
- Support Level
- ABUS $3.42
- AC $35.05
- Resistance Level
- ABUS $3.81
- AC $37.42
- Average True Range (ATR)
- ABUS 0.16
- AC 0.93
- MACD
- ABUS -0.04
- AC -0.07
- Stochastic Oscillator
- ABUS 7.41
- AC 19.86
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified global financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.